I-J Jang

406 total citations
7 papers, 152 citations indexed

About

I-J Jang is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, I-J Jang has authored 7 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 2 papers in Geriatrics and Gerontology and 1 paper in Molecular Biology. Recurrent topics in I-J Jang's work include Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Blood Pressure and Hypertension Studies (2 papers). I-J Jang is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Blood Pressure and Hypertension Studies (2 papers). I-J Jang collaborates with scholars based in South Korea and United States. I-J Jang's co-authors include K‐S Yu, Joo‐Youn Cho, Min‐Ho Choi, Kon Chu, Seo Hyun Yoon, Keun‐Hwa Jung, K.S. Hong, Dongseong Shin, Soyoung Lee and Jaeseong Oh and has published in prestigious journals such as Clinical Pharmacology & Therapeutics and International Journal of Clinical Pharmacology and Therapeutics.

In The Last Decade

I-J Jang

7 papers receiving 149 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I-J Jang South Korea 5 81 37 36 35 29 7 152
Pei-Chieng Cha Japan 7 111 1.4× 57 1.5× 40 1.1× 30 0.9× 66 2.3× 11 225
Suparna Martis United States 9 136 1.7× 55 1.5× 37 1.0× 44 1.3× 47 1.6× 10 314
Shunsuke Eguchi Japan 9 61 0.8× 36 1.0× 50 1.4× 83 2.4× 111 3.8× 20 314
Paulo Caleb Júnior Lima Santos Brazil 12 67 0.8× 14 0.4× 21 0.6× 47 1.3× 55 1.9× 36 286
Marco Chirico Italy 6 183 2.3× 47 1.3× 96 2.7× 38 1.1× 32 1.1× 14 289
Eunice J. Zhang United Kingdom 8 92 1.1× 9 0.2× 34 0.9× 55 1.6× 33 1.1× 11 228
E. Katriina Tarkiainen Finland 9 104 1.3× 73 2.0× 33 0.9× 65 1.9× 38 1.3× 21 297
Jeffrey Rollo United States 8 144 1.8× 16 0.4× 53 1.5× 153 4.4× 56 1.9× 14 345
Amber L. Beitelshees United States 6 94 1.2× 8 0.2× 41 1.1× 70 2.0× 22 0.8× 7 176
К. Б. Мирзаев Russia 9 99 1.2× 15 0.4× 28 0.8× 126 3.6× 21 0.7× 89 299

Countries citing papers authored by I-J Jang

Since Specialization
Citations

This map shows the geographic impact of I-J Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I-J Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I-J Jang more than expected).

Fields of papers citing papers by I-J Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I-J Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I-J Jang. The network helps show where I-J Jang may publish in the future.

Co-authorship network of co-authors of I-J Jang

This figure shows the co-authorship network connecting the top 25 collaborators of I-J Jang. A scholar is included among the top collaborators of I-J Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I-J Jang. I-J Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Oh, Jaeseong, Dongseong Shin, Soyoung Lee, et al.. (2014). Aspirin Decreases Systemic Exposure to Clopidogrel Through Modulation of P-Glycoprotein But Does Not Alter Its Antithrombotic Activity. Clinical Pharmacology & Therapeutics. 95(6). 608–616. 24 indexed citations
2.
Choi, Min‐Ho, et al.. (2013). Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance. Clinical Pharmacology & Therapeutics. 94(5). 601–609. 86 indexed citations
3.
Jeon, Hoonbae, et al.. (2011). Pharmacokinetics and tolerability of probucol after multiple oral administrations in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 49(11). 688–695. 5 indexed citations
4.
Park, Min Kyu, Kwang Pyo Kim, Sang-Hoon Yoon, et al.. (2011). Open label, three period, single sequence, study of 5, 25, 50 mg sertraline pharmacokinetics in healthy male Korean volunteers. International Journal of Clinical Pharmacology and Therapeutics. 49(11). 672–678. 4 indexed citations
5.
Yi, SoJeong, John Kim, Jin Woong Choi, et al.. (2011). Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 49(5). 321–327. 17 indexed citations
6.
Jung, Keun‐Hwa, Kon Chu, Soon‐Tae Lee, et al.. (2011). Prolonged Use of Aspirin Alters Human and Rat Intestinal Cells and Thereby Limits the Absorption of Clopidogrel. Clinical Pharmacology & Therapeutics. 90(4). 612–619. 15 indexed citations
7.
Jang, I-J, Hironori Kikkawa, Xi Lin, et al.. (2006). Assessing the role of ethnicity on cytochrome P450 enzymes: A global/Asian study.. Clinical Pharmacology & Therapeutics. 79(2). 84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026